Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Farmers Insurance
Baxter
Mallinckrodt
Dow
Deloitte
Federal Trade Commission
Harvard Business School
Cerilliant

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,641,843

« Back to Dashboard

Which drugs does patent 6,641,843 protect, and when does it expire?

Patent 6,641,843 protects ZIAGEN and is included in one NDA.

Protection for ZIAGEN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-six patent family members in thirty-eight countries.
Summary for Patent: 6,641,843
Title: Pharmaceutical compositions
Abstract:The present invention relates to pharmaceutical compostions of (1S,4R)-cis-4-[2-amino-6-cyclopropylamino}-9H-purin-9-yl]-2-cyclopentene-1 -methanol (1592U89).
Inventor(s): Brooks; Nikki Thoennes (Glen Allen, VA)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:09/601,671
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Process; Formulation;

Drugs Protected by US Patent 6,641,843

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Viiv Hlthcare ZIAGEN abacavir sulfate SOLUTION;ORAL 020978-001 Dec 17, 1998 AA RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,641,843

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9802472Feb 06, 1998
PCT Information
PCT FiledFebruary 04, 1999PCT Application Number:PCT/EP99/00663
PCT Publication Date:August 12, 1999PCT Publication Number: WO99/39691

International Patents Family Members for US Patent 6,641,843

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovakia 11682000 ➤ Subscribe
Slovenia 1051156 ➤ Subscribe
Serbia 49953 ➤ Subscribe
Yugoslavia 48200 ➤ Subscribe
Portugal 1051156 ➤ Subscribe
Poland 194558 ➤ Subscribe
Poland 342628 ➤ Subscribe
Peru 02712000 ➤ Subscribe
New Zealand 505811 ➤ Subscribe
Norway 329041 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
AstraZeneca
Julphar
Accenture
US Department of Justice
Baxter
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot